Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Biology of Blood and Marrow Transplantation.
Times cited: 1
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.
Nature Reviews Clinical Oncology.
Times cited: 23
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: An open label, single arm, phase II trial.
Clinical Lymphoma, Myeloma and Leukemia.
Times cited: 20
Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma.
Journal of Clinical Oncology.
Times cited: 106